Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/15/21 → 8/30/23 |
Funding
- Alnylam Pharmaceuticals Incorporated: $250,000.00
Targeting Fructose Metabolism for the Treatment of NAFLD and T2D
- Softic, Samir (PI)
| Status | Finished |
|---|---|
| Effective start/end date | 4/15/21 → 8/30/23 |